AGONISTS OF 5-HT4-RECEPTORS FOR TREATING DEMENTIA Russian patent published in 2015 - IPC A61K31/454 A61P25/28 

Abstract RU 2569733 C2

FIELD: medicine, pharmaceutics.

SUBSTANCE: claimed group of inventions relates to medicine, namely to neurology, and deals with treating dementia. For this purpose an effective amount of a compound, possessing the activity of an agonist of 5-HT4-receptors - N-((1-((4-hydroxytetrahydro-2H-pyran-4-yl)methyl)piperidin-4-yl)methyl)-3-isopropyl-2-oxo-2,3-dihydro-1H-benzo[d]imodazole-1-carboxamide is introduced.

EFFECT: medication provides an improvement of the cognitive function and the reduction of the level of the beta-amyloid peptide in case of neurodegenerative diseases.

9 cl, 4 ex, 4 dwg

Similar patents RU2569733C2

Title Year Author Number
ARYL-OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS 2012
  • Kuntts Kevin Uejn
  • Chesuort Richard
  • Dunkan Kennet Uillyam
  • Kajlkhak Khajke
  • Varkholik Natali
  • Klaus Kristin
  • Seki Masasi
  • Sirotori Syudzi
  • Kavano Satosi
  • Vigl Timoti Dzhejms Nelson
RU2632193C2
SUBSTITUTED BENZENE COMPOUNDS 2012
  • Kuntts Kevin Uejn
  • Chesuort Richard
  • Dunkan Kennet Uillyam
  • Kajlkhak Khajke
  • Varkholik Natali
  • Klaus Kristin
  • Natson Sara K.
  • Vigl Timoti Dzhejms Nelson
  • Seki Masasi
RU2629118C2
BENZOFURAN DERIVATIVE, A METHOD FOR PRODUCTION THEREOF AND USE THEREOF IN MEDICINE 2016
  • Lu, Byao
  • Shen, Syaodun
  • Khe, Minsyun
  • Lyu, Dun
  • Chzhan, Minshen
RU2727198C2
PYRAZOLO[3,4-b]PURIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITION (VERSIONS), APPLICATION (VERSIONS), COMBINATION (VERSIONS) 2003
  • Allen Dejvid Dzhordzh
  • Kou Dajan Mehri
  • Kuk Kehrolin Mehri
  • Doul Majkl Dehnnis
  • Ehdlin Kristofer Dejvid
  • Khehmblin Dzhuli Nikol'
  • Dzhonson Martin Redpat
  • Dzhounz Pol Spenser
  • Noulz Richard Grehm
  • Mitchell Sharlott Dzhejn
  • Redgrejv Ehlison Dzhudit
  • Uord Piter
  • Lindvall Mika Kristian
RU2357967C2
SUBSTITUTED BENZENE COMPOUNDS 2013
  • Kuntts Kevin Uejn
  • Kempbell Dzhon Emmerson
  • Seki Masasi
  • Sirotori Syudzi
  • Itano Vataru
  • Chzhen Vantszyun
RU2658919C2
PYRAZOLPYRIMIDINE COMPOUNDS JAK INHIBITORS AND METHODS 2009
  • Blehjni Dzheffri
  • Gibbons Pol A.
  • Khanan Ehmili
  • Lissikatos Dzhozef P.
  • Magnuson Stiven R.
  • Pastor Richard
  • Rouson Tomas E.
  • Chzhou Ajkheh
  • Chzhu Bin-Jan'
RU2539568C2
IMIDAZOTRIAZINONE COMPOUNDS 2011
  • Ripka Emi
  • Shapiro Gideon
  • Makrajner Endrju
RU2603140C2
HETEROCYCLIC COMPOUND 2018
  • Takami, Kazuaki
  • Seto, Masaki
  • Sasaki, Shinobu
  • Ando, Haruhi
  • Ogino, Masaki
  • Ohashi, Tomoko
  • Imaeda, Toshihiro
  • Fujimori, Ikuo
  • Tsukimi, Yasuhiro
  • Yamada, Masami
  • Shimokawa, Kenichiro
  • Wakabayashi, Takeshi
  • Murakami, Masataka
  • Fushimi, Makoto
  • Okawa, Tomohiro
  • Yonemori, Jinichi
  • Ohashi, Tomohiro
  • Suzuki, Hideo
  • Maezaki, Hironobu
  • Sato, Ayumu
  • Asano, Yasutomi
  • Swann, Steve
RU2791533C2
IMIDAZOPYRAZINE OR IMIDAZODIAZEPINE DERIVATIVES, ACTIVE WITH RESPECT TO RECEPTOR CB2 2008
  • Betskett R. Paul
  • Foster Richard
  • Khenault Christelle
  • Ralbovsky Dzhanet L
  • Gauss Karla M
  • Gustafson Gari R
  • Luo Zhijong
  • Kampbell Anna-Mari
  • Shelekkhin Tat'Jana E
RU2540074C2
TREATMENT METHOD 2012
  • Bassil Anna K.
  • Bejnke Seren
  • Prindzhkha Rabinder Kumar
RU2621148C2

RU 2 569 733 C2

Authors

Okhsiro Khirojuki

Fudzijuti Akiesi

Take Jukinori

Dates

2015-11-27Published

2011-02-14Filed